跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 32,689 条关于
“Lewy body–associated psychosis”
全部
32,689
临床试验
19,076
药物
470
机构
135
资讯
13,008
2个月前
Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis
2年前
Cholinesterase Inhibitors Show Promise in Slowing Lewy Body Dementia Progression
去年
Cholinesterase Inhibitors Show Promise in Managing Cognitive Decline in Lewy Body Dementia
5个月前
New Cerebrospinal Fluid Biomarker Achieves 94-97% Accuracy in Diagnosing Parkinson's Disease and Lewy Body Dementia
8个月前
Acadia Pharmaceuticals Projects $1.7 Billion Revenue by 2028, Advances Alzheimer's Psychosis Pipeline
去年
Acadia Pharmaceuticals Unveils $12 Billion Pipeline Strategy at Inaugural R&D Day
去年
Cognition Therapeutics' CT1812 Shows Promise in Phase 2 Trials for Alzheimer's and Lewy Body Dementia
上个月
Acadia Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference
12个月前
Acadia Pharmaceuticals' Phase 3 Trial of Intranasal Carbetocin for Prader-Willi Syndrome Fails to Meet Primary Endpoint
去年
Nilotinib Shows Promise in Dementia with Lewy Bodies
第 1 页，共 1301 页
上一页
下一页
